Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
Loading GALE News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.13%||67.83||1.0%||$601.46m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.50%||369.14||2.1%||$315.18m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.16%||120.08||1.6%||$211.26m|
|KITE||Kite Pharma, Inc.||-0.38%||76.38||18.8%||$203.08m|
|ESPR||Esperion Therapeutics, Inc.||-0.10%||39.01||18.7%||$159.25m|
|AUPH||Aurinia Pharmaceuticals Inc.||1.91%||8.53||6.3%||$142.55m|
|CLVS||Clovis Oncology, Inc.||3.99%||67.18||17.5%||$139.83m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.60%||90.04||2.2%||$135.42m|
Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.